Company-wide revenue
Reported revenue in 2022 ¥10.01B Reported revenue in 2025 ¥1.31B
- growth amount
- −¥8.7B
- growth annualized
- -49.3%
- growth total
- -86.9%
Japanese company profile · 4582
SymBio Pharmaceuticals Limited
In its FY2025 public filing, SymBio Pharmaceuticals Limited reports Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: シンバイオ製薬株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
SymBio Pharmaceuticals Limited's largest reported business by revenue in FY2025 was Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services | ¥1.31B ↗ | 100.0% | −¥4.44B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services
- 医薬品等の研究開発及び製造販売並びにこれらの付随業務
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services
- 医薬品等の研究開発及び製造販売並びにこれらの付随業務
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Research, Development, Manufacturing and Sales of Pharmaceutical Products and Related Services | ¥10.01B | ¥5.59B | ¥2.45B | ¥1.31B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XNE5
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.